Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

UK2

NHS National Generics Pharmaceuticals - Supply Chain Resilience

  • First published: 22 January 2026
  • Last modified: 22 January 2026
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
ocds-h6vhtk-060abf
Published by:
NHS England
Authority ID:
AA20005
Publication date:
22 January 2026
Deadline date:
28 January 2026
Notice type:
UK2
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

NHS National Generics Pharmaceuticals - Supply Chain ResiliencePeriod of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.Periods of call-offs under the framework agreement:CM/PHG/25/5739/01 – Orals (plus non-parenteral) ProductsCESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months)NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months)LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months)CM/PHG/25/5739/02 – Hospital Only ProductsDLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months)DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months)DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)

Full notice text

Scope

Procurement reference

CM/PHG/25/5739

Procurement description

NHS National Generics Pharmaceuticals - Supply Chain Resilience

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

Periods of call-offs under the framework agreement:

CM/PHG/25/5739/01 – Orals (plus non-parenteral) Products

CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months)

NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months)

LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months)

CM/PHG/25/5739/02 – Hospital Only Products

DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months)

DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months)

DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)

Main category

Goods

Total value (estimated)

52447296.00 GBP Excluding VAT

62936755.00 GBP Including VAT

Contract dates (estimated)

01 September 2026, 00:00AM to 31 May 2028, 23:59PM

Extension end date (if all the extensions are used): 31 August 2030

Is a framework being established?

Yes

Contracting authority

NHS England

Identification register:

  • GB-PPON

Address 1: Wellington House, 133-135 Waterloo Rd

Town/City: London

Postcode: SE1 8UG

Country: United Kingdom

Website: https://www.england.nhs.uk/

Public Procurement Organisation Number: PDPT-3135-BWWY

NUTS code: UKI45

Email: england.generics@nhs.net

Organisation type: Public authority - central government

Lots

Divided into 1 lots

Lot number: 1

CPV classifications

  • 33600000 - Pharmaceutical products

Sustainability

Small and medium-sized enterprises (SME)

Contract start date (estimated)

01 September 2026, 00:00AM

Contract end date (estimated)

31 May 2028, 23:59PM

Extension end date (estimated)

31 August 2030, 23:59PM

Can the contract be extended?

Yes

Engagement

Engagement process description

NHS England is advising suppliers of an upcoming tender for the NHS National Generics Pharmaceuticals - Supply Chain Resilience, to commence on 1st September 2026 for varying dates of up to 21 months with options to extend for a maximum total contract period of 48 months. This procurement will largely consist of previously terminated products of hospital only and oral (plus non-parenteral) products across all regions of the country. The purpose of this notice is to inform existing and potential new suppliers of this procurement. Useful information for suppliers can be found here www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ . Specific information regarding the products included in this procurement will be provided in the ITO which will be issued shortly.

Due date

28 January 2026, 23:59PM

Has the engagement period already ended?

No

Submission

Publication date of tender notice (estimated)

30 January 2026

Coding

Commodity categories

ID Title Parent category
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
N/a
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.